- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High ROE Growth Engines
U.S. Pharmaceuticals & Biotech High ROE Growth Engines
Results
5
5 companies
Exelixis
Market Cap: US$11.7b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$42.88
7D
1.2%
1Y
95.5%
ACADIA Pharmaceuticals
Market Cap: US$3.6b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$21.47
7D
-2.3%
1Y
40.5%
Agios Pharmaceuticals
Market Cap: US$1.9b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
AGIO
US$32.63
7D
9.5%
1Y
-25.6%
CureVac
Market Cap: US$1.0b
A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
CVAC
US$4.63
7D
13.2%
1Y
6.7%
Niagen Bioscience
Market Cap: US$854.1m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$11.73
7D
18.7%
1Y
300.3%